Trial Profile
Pharmacokinetic evaluation of daclatasvir (DCV) and ribavirin (RBV) in HIV–HCV co-infected patients treated with daclatasvir, sofosbuvir, and ribavirin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 22 Feb 2017 New trial record